• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON MEDICAL (SINGAPORE) NEOFLON PRO 24GA 0.7MM OD 19MM L; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON MEDICAL (SINGAPORE) NEOFLON PRO 24GA 0.7MM OD 19MM L; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 391380
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Extravasation (1842)
Event Date 09/05/2020
Event Type  Injury  
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.Medical device expiration date: unknown a device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.Device manufacture date: unknown.Fda device problem code: 2993.Fda patient problem code: 1842.
 
Event Description
It was reported that neoflon pro 24ga 0.7mm od 19mm l was used and infiltration and extravasation occurred.This was discovered during use.The following information was provided by the initial reporter: the physician complaint is that since they start using neoflon pro, they have more venipuncture attempts, the catheter blood chamber is not filling completely as before and it take more time for the blood visualization in the blood chamber.The main issue as they say is the instaflush, they have more infiltration and extravasation cases and in particularly with small neonates (500g).
 
Event Description
It was reported that neoflon pro 24ga 0.7mm od 19mm l was used and infiltration and extravasation occurred.This was discovered during use.The following information was provided by the initial reporter: the physician complaint is that since they start using neoflon pro, they have more venipuncture attempts, the catheter blood chamber is not filling completely as before and it take more time for the blood visualization in the blood chamber.The main issue as they say is the instaflush, they have more infiltration and extravasation cases and in particularly with small neonates (500g).
 
Manufacturer Narrative
H.6.Investigation: no photos or samples were received by our quality team for evaluation therefore the failure mode could not be verified.A device history record could not be evaluated as the lot number is unknown.Based on the quality team's investigation, the root cause of this incident cannot be determined.Based on the verbatim, the neoflon pro product seem to be functioning as intended.H3 other text : see h.10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEOFLON PRO 24GA 0.7MM OD 19MM L
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON MEDICAL (SINGAPORE)
30 tuas avenue 2
singapore
MDR Report Key10606166
MDR Text Key209197431
Report Number8041187-2020-00629
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 10/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Catalogue Number391380
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/05/2020
Initial Date FDA Received09/30/2020
Supplement Dates Manufacturer Received09/05/2020
Supplement Dates FDA Received10/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-